Shafique Virani, Chief Business Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 20,000 shares at $11.21 ($218K) on 2022-10-14, disclosed to the SEC on 2022-10-18.
Open-market sale of $218k RXRX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.63 | 5,000 | $53K | 24.3% |
| 2 | $10.63 | 5,000 | $53K | 24.3% |
| 3 | $11.21 | 5,000 | $56K | 25.7% |
| 4 | $11.21 | 5,000 | $56K | 25.7% |
| Total | $10.92 avg | 20,000 | $218K | 100% |
| Filing → |
| RXRX | SELL | 2023-11-17 | $117K | — | Filing → |
| RXRX | SELL | 2023-10-18 | $113K | — | Filing → |
| RXRX | SELL | 2023-09-19 | $156K | — | Filing → |